This paper entitled, "In vivo metallophilic self-assembly of a light-activated anticancer drug", presents a novel approach to design self-assembling molecular drugs that can form stable supramolecular nanostructures in living mice and act as light-activated anticancer agents. The paper demonstrates that the metallophilic interaction between cyclometalated palladium complexes is strong enough to generate supramolecular nanostructures in vivo, which have a long circulation time and efficient tumour accumulation rate in a skin melanoma tumour model. The paper shows that green light activation leads to efficient tumour destruction due to the type I photodynamic effect generated by the self-assembled palladium complexes, as confirmed by in vitro and in vivo experiments. The paper provides a new strategy to use small molecules as nanodrugs directly in vivo, without the need of dedicated nanocarriers, and introduces metallophilic interactions as a new tool for nanomedicine.